Literature DB >> 31882488

Matrix Metalloproteinases (MMP-2,-3,-9) Gene Polymorphisms in Cases of Benign Vocal Fold Lesions and Laryngeal Carcinoma.

Vykintas Liutkevicius1, Vaiva Lesauskaite2, Rasa Liutkeviciene3, Paulius Vaiciulis4, Virgilijus Uloza4.   

Abstract

BACKGROUND/AIM: The matrix metalloproteinases (MMP) play an important role in the physiological and pathological remodeling of tissues including carcinogenesis. The study's aim was to assess the relations between MMP-2(-735C/T), MMP-2(-1306C/T), MMP-9(-1562C/T), and MMP-3(-11715A/6A) polymorphisms, and clinical/morphological manifestation of laryngeal squamous cell carcinoma (LSCC) and benign vocal fold lesions (BVFL). PATIENTS AND METHODS: Two hundred and seventeen patients with LSCC and BVFL and 458 controls were included in this study. The genotyping was performed using the real-time polymerase chain reaction method.
RESULTS: The MMP-2(-1306C/T) C/T genotype was significantly rarer among the patients with moderate-poorly differentiated LSCC compared to the control group, however the MMP-3(-11715A/6A) 6A/6A genotype was significantly more frequent compared to controls. Smoking and 6A/6A genotype of MMP-3(-11715A/6A) polymorphism were associated with increased odds of LSCC risk. No associations between MMP genotypes and BVFL were found.
CONCLUSION: Smoking and MMP-3 (-11715A/6A) 6A/6A genotype may cause a higher risk for developing LSCC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Laryngeal squamous cell carcinoma; benign vocal fold lesions; gene polymorphism; matrix metalloproteinases

Mesh:

Substances:

Year:  2020        PMID: 31882488      PMCID: PMC6984121          DOI: 10.21873/invivo.11770

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  44 in total

Review 1.  Control of matrix metalloproteinase catalytic activity.

Authors:  Hyun-Jeong Ra; William C Parks
Journal:  Matrix Biol       Date:  2007-07-07       Impact factor: 11.583

Review 2.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

Authors:  S Ye
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

3.  MMP-2 expression in 102 patients with glottic laryngeal cancer.

Authors:  Antony Mallis; Afshin Teymoortash; Nicholas S Mastronikolis; Jochen A Werner; Theodoros A Papadas
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-11       Impact factor: 2.503

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

5.  Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.

Authors:  A Samnegård; A Silveira; P Lundman; S Boquist; J Odeberg; J Hulthe; W McPheat; P Tornvall; L Bergstrand; C-G Ericsson; A Hamsten; P Eriksson
Journal:  J Intern Med       Date:  2005-11       Impact factor: 8.989

6.  Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.

Authors:  Ajay K Chaudhary; Mamta Singh; Alok C Bharti; Mangal Singh; Shirish Shukla; Atul K Singh; Ravi Mehrotra
Journal:  BMC Cancer       Date:  2010-07-14       Impact factor: 4.430

7.  Role of MMP-2 (-1306 C/T) Polymorphism in Age-Related Macular Degeneration.

Authors:  Rasa Liutkeviciene; Vaiva Lesauskaite; Diana Zaliaduonyte-Peksiene; Giedre Sinkunaite-Marsalkiene; Dalia Zaliuniene; Vaida Mizariene; Olivija Gustiene; Vytautas Jasinskas; Abdonas Tamosiunas
Journal:  Ophthalmic Genet       Date:  2015-09-02       Impact factor: 1.803

8.  A protective role for matrix metalloproteinase-3 in squamous cell carcinoma.

Authors:  Lisa J McCawley; Howard C Crawford; Lloyd E King; John Mudgett; Lynn M Matrisian
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

9.  Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study.

Authors:  Anne Peasey; Martin Bobak; Ruzena Kubinova; Sofia Malyutina; Andrzej Pajak; Abdonas Tamosiunas; Hynek Pikhart; Amanda Nicholson; Michael Marmot
Journal:  BMC Public Health       Date:  2006-10-18       Impact factor: 3.295

10.  The 2G allele of promoter region of matrix metalloproteinase-1 as an essential pre-condition for the early onset of oral squamous cell carcinoma.

Authors:  Rishiho Nishizawa; Masaki Nagata; Arhab A Noman; Nobutaka Kitamura; Hajime Fujita; Hideyuki Hoshina; Takehiko Kubota; Manami Itagaki; Susumu Shingaki; Makoto Ohnishi; Hiroshi Kurita; Kouji Katsura; Chikara Saito; Hiromasa Yoshie; Ritsuo Takagi
Journal:  BMC Cancer       Date:  2007-10-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.